Copy number variation (CNV) is an important type of mutation in the human genome, and is significantly associated with cancer and other diseases. Accurate detection of CNVs in tumor genomes is crucial for biologists aiming to understand tumorigenesis. One of the key steps in this task is to establish a reasonable model to conduct meaningful assessment of each genome region. Although a great number of computational approaches have been developed in the past few years, none of them is versatile enough to detect CNVs in all scenarios associated with complex genomes. In this paper, we propose a new statistical approach, called CRSCNV, to detect CNVs in individual samples, based on next-generation sequencing data. The approach adopts a cross-model-based statistical strategy to test the significance of genome bins, i.e., the genome to be analyzed is divided into N parts. The bins in each part are tested by establishing a statistical model based on the remaining (N − 1) parts. The advantage of such a cross model is that it can improve the meaning of P-value assessment. We tested the performance of CRSCNV on a large number of simulation datasets and compared it to the state-of-the-art methods. The results demonstrated that CRSCNV achieved the best trade-off between recall and precision. We further validated CRSCNV, using several real sequencing samples, where it produced a number of previously reported CNVs and some additional CNVs with potential biological importance. Thus, CRSCNV is a reliable approach for CNV detection, even in scenarios of extremely low purity.
I. INTRODUCTION
Copy number variation (CNV), as a major type of genomic variation, plays an important role in human cancer and other complex diseases [1] - [4] . CNV is a typical mediumscale structural variation, and is defined as a DNA fragment that is amplified or deleted at fragments of one kilobases or larger than the length of the reference genome [5] . Many studies have shown that more than 12% of the human genome underwent copy number variations [6] . These CNVs in the human body are responsible for many human diseases, such as cancer, autism, neuropsychiatric diseases, The associate editor coordinating the review of this manuscript and approving it for publication was Qingchao Jiang . autoimmune disorders, psoriasis, and huntingtin's disease [7] - [12] . The CNVs in the human genome are generally considered of similar importance as single nucleotide variants, small deletions or insertions, and large structural variants. Some researchers have found that there a large number of CNVs occur within protein coding regions [13] . The amplification and deletion of DNA fragments directly affects the copy number of the genes and the genes' expression level in the relevant regions. It is reported that not all CNVs are harmful to human health, but they may indirectly affect it [14] . Furthermore, CNVs make a very important contribution to genetic analysis and our understanding of human evolution [15] - [19] .
Traditional technologies designed to detect CNVs were based mainly on fluorescence in situ hybridization (FISH) [20] , single-nucleotide polymorphism (SNP) array approaches, and array comparative genomic hybridization (aCGH) [21] . The detection resolution of FISH is relatively low. It can only detect up to 5 to 10 megabases [22] . Nevertheless, the emergence of SNP array approaches and aCGH made it possible to detect CNVs in whole genomes. The inherent drawbacks of these approaches include low resolution, hybridization noise, and limited genome coverage [23] , [24] . Therefore, the traditional technologies are not powerful enough to detect rare and novel CNVs.
Recent developments in next generation sequencing (NGS) technologies provide a wealth of cost-effective data at single-base resolution for genome variations detection [19] . Compared to microarray-based sequencing methods, NGS technologies have many obvious advantages: higher resolution, unlimited genome coverage, more accurate detection of breakpoints, more precise calculation of copy numbers, and the ability to detect complicated CNVs [25] . A number of computational methods dedicated to using the data generated by NGS technologies have been developed. These methods could be classified into four categories: paired-end mapping (PEM) [26] , depth of coverage (DOC), split read (SR), and de novo assembly (DAS). Each of them has its own advantages, disadvantages, and application scope. The SR-based method can detect the exact breakpoint, using split read, but it is not suitable for detecting multiple repetitive regions, and this can result in the detected breakpoints being not unique. The DAS-based method can detect CNVs and other structural variations, but it is not suitable for detecting long repetitive regions in the reference genome. The other two methods, PEM and DOC, are the most commonly used methods and we will expand on them. The PEM-based method can detect copy number losses and gains as well as inversions and translocations. The method is only used for paired-end sequencing. In theory, the PEM method can detect various types of CNVs, but in reality, it is not suitable for detecting smaller CNVs, and it cannot detect the exact boundaries of the CNVs. It is also not suitable for detecting large gains whose length is greater than the detected DNA fragment, a length that is predefined by library preparation [27] . The detection principle of PEM method is the alignment of a pair of reads that come from a detected DNA fragment and the reference genome. If the distance of two reads is not equal to the average insertion size of the detected DNA fragment, then we can conclude the occurrence of CNV. In the DOC method, sequence reads are randomly extracted from the genome. These reads are compared to the reference genome and the number of detected reads that are aligned to each location of the reference genome are proportional to the copy number at that location [22] . Copy number gain areas would have a higher density than in normal areas, whereas copy number loss areas would have a lower density than expected [28] . The DOC method is very suitable for detecting CNVs, but it is not able to accurately detect the boundaries of CNV regions. Therefore, this method can easily lead to false positive test results. Both single-end reads and paired-end reads can be used by the DOC methods, so it can detect any length of copy number gain or loss. Most CNV detection methods are developed based on DOC, including FREEC [29] , CNVnator [30] , GROM-RD [31] , and iCopy-DAV [32] . These methods can predict copy number gains and losses using read count information. Their workflow is generally along these steps [33] : (1) Extracting read count files. (2) Setting the size of bins [34] . (3) Data pre-processing. This step generally includes GC-content calculation and mappability bias correction [35] , sequencing and experimental noise cancelation [36] , tumor samples contamination [37] and more. These factors will affect the correctness of the final test results. (4) segmentation and CNVs prediction [38] , [39] . Keeping in mind the above theory, we further analyze the advantages and limitations of several popular CNV detection methods. FREEC can use GC-content bias correction, which generates segmented smooth profiles, to predict CNVs [29] . The performance of FREEC is balanced and it scores high in simulation experiments. CNVnator predicts CNVs using mean-shift method with multiple-bandwidth partitioning and GC correction [30] . CNVnator is not sensitive enough to detect short CNVs. GROM-RD evaluates CNVs by correcting GC-content and repeat bias [31] . Its performance is limited to detecting low purity tumor samples. iCopyDAV is a comprehensive software platform [32] , which is suitable for detecting CNVs in high purity tumor samples. In general, the above methods can detect a large proportion of CNVs, but they are not very effective in case samples are of low tumor purity.
With consideration of the issues above, in this paper we propose a new method, CRSCNV (Cross-model based statistical approach for CNV detection), to detect CNVs by using NGS data from single tumor samples. The key idea is grouping the whole genome into N -folds, (N − 1)-folds of which establish N statistical distributions. These are used to test the significance of genomic bins from the remainder 1-fold. (N −1)-folds and 1-fold are mutually exclusive in each test, which reduces the conservativeness of the test results and makes it easier to find inconspicuous variations. In order to verify the validity of the method, we tested the performance of CRSCNV based on both simulation and real sequencing datasets. CRSCNV achieved the best trade-off between high recall and medium precision, when compared with several published methods in the simulation experiments. In the real data experiments, CRSCNV detected many valuable CNVs that proved to be clinically relevant, and are associated with cancer and other diseases. CRSCNV is demonstratively an effective and reliable CNV detection tool.
II. METHODS

A. OVERVIEW OF CRSCNV
CRSCNV is a DOC-based method designed to detect CNVs using NGS data. It is suitable for testing single tumor samples without the requirement of matched normal samples. The workflow of the CRSCNV method is described in Fig.1 . It consists of four main steps. In the first step, a tumor sample formatted as a FASTQ file and a reference (e.g., GRCh37) formatted as a FASTA file are prepared for the input to the algorithm. An alignment process is performed by using the popular alignment tool BWA [40] , which will produce the alignment results formatted as a SAM file. A read count (RC) profile is further extracted by using SAMtools [41] . In the second step, we define the size of bins that are continuous and non-overlapping. The RC profile is binned to generate read depth (RD) profile. We then filter out the abnormal bins, remove GC-content bias, eliminate RD noise, and equalize the RD signal. In the third step, the method performs the division operation. The RD profile is divided into N equal-sized mutually exclusive segments. We choose one of the N segments as the detected data, and use the remaining (N -1) segments to build a Gaussian model, which can generate N test sets and N mutually exclusive Gaussian models. Finally, in the fourth step, we calculate the P-value of each bin, using crossmodel. Here, we use hypothesis testing to predict CNVs, and choose a significance level (α) threshold. If P-value of a bin is less than α, it is considered to be a CNV region. If P-value of a bin is greater than α, it is considered to be a normal region.
B. DATA PREPROCESSING
The data preprocessing step is divided into four parts: (1) Filtering outlier bins. (2) GC-content bias correction.
(3) Eliminating data noise. (4) Equalizing the read depth signal. We will describe the preprocessing process in detail in the following sections.
1) FILTERING OUTLIER BINS
RC profile is a series of read counts for positions across the whole genome to be analyzed. In the reference genome, a large number of uncertain bases are replaced by 'N' [42] . When a read is compared to a position of 'N', then the RC will be equal to zero. The reads are composed of 'A', 'T', 'C' and 'G' so, in the absence of a match for 'N', a zero is used. Removing the positions would introduce mistakes and loss of CNV areas. In order to solve this problem, we use the following method to process the data. We record all 'N' and non-'N' positions in the reference genome. We then make the RC of each 'N' position equal to 'NA' that indicates missing data, and the RC of each non-'N' position equal to zero. According to the positions of RCs in the read count profile, we assign the RCs of the read count profile to the RCs of the reference genome. It can be calculated by the following Formula (1) .
where RC b represents the sum of all RCs in a bin, and bin l represents the length of a bin. In this work, we set bin l length to 1000 bp. If RD is equal to 'NA', the bin is filtered out.
2) GC-CONTENT BIAS CORRECTION
The GC-content bias is caused by PCR amplification [35] . GC-content is defined as the ratio between the number of 'G' and 'C' and the total number of all bases in a bin [43] - [45] . We can calculate it using Formula (2) .
where RD i is RD of the i-th bin after correction, RD m denotes mean of RDs of all bins, RD i denotes RD of the i-th bin, and RD gc denotes mean of RDs of the bins that are composed of other bins and i-th bins that have the same GC-content.
3) NOISE CANCELLATION
The noise of the RD data is generated during the sequencing process. If we use data with noise, the test results will be inaccurate. Therefore, it is necessary to eliminate the noise of the RD data. Here, we use a total variation method to eliminate noise. The algorithm can reduce noise or smooth one-dimensional discrete signals, using the regularized total variation and least-squares approaches [46] , [47] . In the algorithm, we use pre-processed RD profile as input. If two adjacent RD signals differ only slightly, they will be merged into one signal. We use Formula (3) to fit the RD signals.
where RDS [i] represents the RD signal of the i-th bin, RDS [i] represents denoised RD signal of the i-th bin, and M represents the total number of RD signals. Function of the first item is error fitting between RDS [i] and RDS [i]. If a change-point appears between RDS [i] and RDS [i + 1], the second term here represents the imposed total variation penalty. λ represents a penalty factor, which can adjust the tradeoff between the fitting error and penalty caused by the change-points. It is very important and difficult to choose the appropriate value of λ [35] . If the value of λ tends to zero, the penalty role is neglected. If the value of λ tends to infinity, the error fitting role is neglected [35] . In this study we chose the appropriate value of λ based on algorithm debugging.
4) EQUALIZING RDs
The DOC-based method has difficulty in detecting the copy number loss areas where the signal is not significant. The copy number of a normal area is 2. The copy number of a copy number loss area is 0 or 1. Therefore, the loss areas can be difficultly told apart from normal areas. The signals of loss areas and gain areas are unsymmetrical relative to the signal of normal areas. In order to better detect the insignificant loss areas, we used Formula (4).
Before applying Formula (4), the RD sequence is sorted in ascending order. In the formula, RD i denotes RD of the i-th bin after equalization process, RD b denotes the mean value of the last n RDs of the RD sequence, RD f denotes the mean value of the first n RDs of the RD sequence, RD i denotes RD of the i-th bin, RD m represents the mode of all RDs. The setting of n is described in the supplementary file. By equalizing the RD signals [42] , some insignificant loss areas are detected. These are verified by our simulation experiments.
C. MODELING AND CNVS PREDICTION
Here, we need to establish a cross-model to evaluate the significance of each bin, using the preprocessed RDs, and to use hypothesis testing to predict CNVs. This section mainly introduces the cross-model establishment process and CNVs prediction method.
1) DIVIDING
The dividing of the genome includes two steps. In the first step, we divide the RD sequence into N -folds, and use Formulas (5), (6) , and (7) to define this step.
In Formula (5), we define a list (L) that represents the RD sequence, one vector (V) represents 1-fold, the division is continuous and non-overlapping. In Formula (6), V i , that is composed of V l RDs, represents any vector in the L, the RD represents read count of a bin. V l can be calculated by Formula (7), where V l denotes the length of the vector, RD l denotes the length of the RD sequence, RD l %N denotes the remainder of RC l divided by N . The second step is a discontinuous and mutually exclusive dynamic division based on the first division. It is expressed by Formulas (8) and (9) .
In Formula (8), L i , which is composed of two parts, indicates dynamically divided L, V i indicates any vector in L, V i that can be calculated by Formula (9) indicates the difference between L and V i . Each element of L i , V i and V i can be calculated by Formula (6).
2) MODELING
Based on the divided RD sequence, we built a cross-model that was composed of N test sets and N statistical models called CRSCNV, to assess the significance of each bin. The V i that was used as test sets has N possibilities, and could generate N test sets. The V i that was used as training sets had N possibilities, and could generate N training sets. The
When the number of RDs is extremely large, they approximate a Gaussian distribution [48] . In order to calculate the
, a t statistic, defined by Formula (10) was used. The equation is described in detail in the supplementary file.
, which is a t-transformed statistic.
3) EVALUATING THE P-VALUES
We calculate the P-value of ∼ V i [k], using Formulas (11), (12) and (13) , the derivation process of which is described in the Supplementary File.
where the erf (x) is an error function [49] - [51] , P l ( 
The null hypothesis was defined as the absence of CNVs in V i , and the alternative hypothesis was defined as the presence of CNVs in V i . We chose a significance level (α) as the threshold. If P l (
is less than α, it is considered a candidate CNV region.
4) FORECASTING CNVs
According to the above analysis, we further determined the copy number variation type (loss or gain) of
. The basic principle of the DOC-based method for determining the CNV type is that the size of the RD is proportional to the copy number of the corresponding positions. 
D. MODEL PARAMETERS SETTING
Suitable parameter setting is very important for an efficient usage of the method. For this, we briefly describe how to set the parameters according to our experience and with reference to other methods. In the algorithm of CRSCNV, there are three major parameters: bin size (bin l ), number of folds (N ), and the significance level (α). In our work, the default settings for the three parameters (bin l , N, and α) were 1000, 10, and 0.05, respectively. In general, it is recommended to set bin l to 1000-5000, meeting the different resolution needs of the users. The most common value for N is 10. For example, a data set is usually divided into 10-folds in cross-validation [52] . The setting of N is very important, as it will affect the execution time of the method. In the hypothesis test, α is generally set to 0.05 or 0.01.
III. RESULTS AND DISCUSSION
The CRSCNV program is written in both R and Python languages. It is very easy to install and is freely available at https://github.com/gj-123/CRSCNV, where a manual for the software package is also available. To verify the validity of the method, we applied it to several sets of simulation and real data sets. To ensure fairness of the comparison, our default values were set as the parameters of all tested methods. In the simulation experiment, CRSCNV was compared to five published methods (FREEC, SeqCNV, GROM-RD, CNVnator and iCopyDAV). We used three indicators (recall, precision and F1-score) to evaluate the performance of the six methods. To further verify the effectiveness of CRSCNV, it was tested on five real data sets. We used overlapping density score indicator to evaluate the reliability of CRSCNV, and analyzed the biological significance of the alignment results, many of which were related to cancer and other complex diseases.
A. SIMULATION DATA TEST
We applied the IntSIM software to generate the simulation data sets [53] . The reference genome was chromosome 21 of hg19 that was imported into the IntSIM software. Before generating simulation data, there were two important parameters that needed to be set in the software. One parameter was tumor purity (TP) and the other was sequencing coverage (SC). TP was set to 0.2 to 0.5 and SC was set to 4x or 6x. There were 50 samples in each set of settings. Fourteen CNV regions, six gains and eight losses, were present in each sample. The length of CNV areas were set to 10,000 to 50,000 bp.
Here, performance of the six methods was evaluated by calculating the three indicators (recall, precision and F1-score). The recall was defined as the ratio between the number of correctly detected CNVs by a method and the total number of correct CNVs that could be counted in the ground truth file [54] . The precision was defined as the ratio between the number of correctly detected CNVs and total number of detected CNVs by a method [54] . The number of correctly detected CNVs could be counted by calculating the number of intersections of detected CNVs by a method and comparing it to the CNVs in the ground truth file. The test results of the three performance indicators calculated for the six methods, under different TPs and SCs, are shown in Fig.2 . The overall trend shows that performance of the six methods gradually increased with increasing TP. When SC remained unchanged, the higher the TP, the better the test results, indicating that all the method were very sensitive to TP. When TP was equal to 0.5 and SC was equal to 6x, GROM-RD showed the highest precision, but its recall was low. This fact shows that it detected less CNVs. CRSCNV achieved the best recalls under each set of conditions, which shows that it detected many of the CNVs, most of which were correct when compared with the ground truth file.When SC was equal to 6x, the recalls of CRSCNV were more precise than the other five methods. Some insignificant hemi-loss CNV regions were detected by CRSCNV because of its mutual exclusion characteristics. When TP was equal to 0.2 and SC was equal to 6x, CNVnator showed the lowest precision as it detected a large number of long CNV regions, most of which were false positive CNV loss regions. When TP was equal to 0.5 and SC was equal to 4x, iCopyDAV demonstrated the highest precision, but the lowest recall. It detected relatively few CNVs that were really correct CNVs. The FREEC method achieved a better tradeoff between recall and precision. SeqCNV and GROM-RD, whose performance was almost the same, exhibited low recall and high precision in each set of settings. When SC was equal to 4x, the performance of GROM-RD was better than SeqCNV. When SC was equal to 6x, the performance of SeqCNV was better than GROM-RD. It is noteworthy that CRSCNV achieved the best recall results, with a medium precision. Through the above analysis, it is clear that the performance of CRSCNV was the most balanced. On the whole, CRSCNV achieves the highest F1-score when compared with the other five methods. It was followed, in descending order, by FREEC and SeqCNV, GROM-RD, CNVnator, and iCopyDAV.
To further analyze the effectiveness of the six methods based on the above test results, we counted mean of the total number of correctly detected CNVs (VN) under each set of condition, as presented in detail in Fig.3 . The figure shows that CRSCNV got seven times the highest VN, FREEC got the highest VN, SeqCNV, GROM-RD, and CNVnator achieved medium VNs, and iCopyDAV got the lowest VNs. The VR is defined as the ratio between the total number of valid marks of correctly detected CNVs by a method and the total number of marks of correct CNVs that can be calculated using the ground truth file under each set of conditions. The total number of valid marks of correctly detected CNVs can be obtained by calculating the intersections between marks of correctly detected CNVs by a method and the marks of CNVs in ground truth file. The comparisons of VR for the six methods are described in detail in Fig.4 . CRSCNV got the best VRs, followed, in decreasing order, by FREEC, CNVnator, SeqCNV, GROM-RD, and iCopyDAV.
To further evaluate the effective marks of each CNV detected by the six methods, we design Formula (14) . The equation evaluates the validity score (V-score), which can indirectly reflect the distance between the detected CNVs and the breakpoints.
where VN and VR have been defined in the above content. The comparison results of each method are shown in Table 1 . From the table it is clear that CRSCNV achieved the highest V-score in each set of settings.
B. DETECTING REAL DATA FROM THE 1000 GENOMES PROJECT
We used three real samples (NA19238, NA19239 and NA19240) from the 1000 Genomes Project to verify the performance of CRSCNV. Here, we chose four methods (GROM-RD, FREEC, CNVnator, and CNVkit [55] ) to compare with CRSCNV. In Fig.5 , we show the number of CNV events detected by each of the methods in the three samples, and the number of overlapping events detected by any two methods. For example, CRSCNV detected 76 events, and 20 overlapping events with GROM-RD in the NA19238 sample. CRSCNV got the most overlapping events and more CNV events than three of the four other methods in the three samples. GROM-RD detected the most candidate CNVs but had fewer overlapping events in each sample. FREEC and CNVnator detected fewer CNVs, most of which were long CNV regions and overlapping events. CNVkit detected the least candidate CNVs and overlapping events in each of the samples. To verify the effectiveness of the five methods, we calculated overlapping density score (ODS) for each method using Formula (15) [42] .
where M o denotes the mean number of overlapping events (intersection between one method's calls and the calls of the other methods). M p denotes the ratio between M o of a method and the total number of CNVs detected by it. The ODSs of the five methods are shown in Table 2 . It is clear that CRSCNV achieved the highest ODSs in each sample, and FREEC and CNVnator were in second or third places. GROM-RD obtained the lowest ODS for NA19239 and NA19240. It detected many CNVs, but most of them did not overlap with events detected by the other methods. CNVkit received the lowest ODS for NA19238. To further analyze the performance of each method, we calculated their sensitivity and precision. In experiments with real data, we could not know the ground truth about the data. Therefore, we could not directly calculate sensitivity and precision. Here, we defined overlapping events as True Positives. We chose the test result of each method as the ground truth, and calculate the sensitivity and precision of the other methods in each alignment [56] . The results are recorded in supplementary Tables S2, S3 and S4. By analyzing the results, CRSCNV showed the best trade-off between sensitivity and precision when compared with the other four methods. The above ODS analysis supported the indication that CRSCNV is an effective method to detect CNVs. Referring to the CNVs of three samples in the DGV database, we calculated sensitivity and precision of five methods that are recorded in supplementary Table S6 .
C. ANALYSIS OF TWO BREAST CANCER SAMPLES
To further validate CRSCNV, we applied it to detect CNVs in two breast cancer whole genome samples. The samples, PD4088 and PD4192, can be downloaded from https://www.ebi.ac.uk. The two samples were in the bam file format. Using the SAMtools [41] , read count files of 22 autosomes were generated and used to detect CNVs. We chose three methods (GROM-RD, FREEC and CNVnator) to compare with CRSCNV. GROM-RD could not detect any CNV in either of the two breast cancer samples. In Fig.6 , we show the number of overlapping events between any two methods and events detected by each method, with the exception of GROM-RD. The number of overlapping events detected by CNVnator was the lowest, although it detected the highest number of CNV regions, many of which were relatively long CNVs and might have been false positive detections. FREEC detected fewer CNVs, but most of them belonged to events overlapped with the other two methods. The number of CNVs detected by CRSCNV was between FREEC and CNVnator, however, CRSCNV got the highest number of overlapping events. We calculated ODSs of the three methods using Formula (15) . The results are displayed in Table 3 . CRSCNV obtained the highest ODSs in the two samples, followed by FREEC and CNVnator. In Fig.7 we show an overview of detected CNVs distribution by the three methods when evaluating 22 autosomes from the two whole genome breast cancer samples. In the FIGURE 6. The first and second columns indicate the detection result of PD4088 and PD4192 samples, respectively. The Red, purple and blue colors represent CRSCNV, FREEC and CNVnator, respectively. The overlapping part of every two ellipses indicates the number of overlapping events of those two methods. Each of the ellipses contain two numbers. The sum of these numbers is the total number of detected events by that method. We further analyzed the biological significance of the detected CNV regions and found that many of them were associated with cancer or other complex diseases. For example, the CNV gains at 1p11.2 [57] , 1q21.3 [58] , and 17q23 [59] , [60] are associated with breast cancer. CNV gains at 14q11.2 [61] , 16p11.2 [62] , and 13q34 [63] are related to lung cancer, autism, and hepatocellular carcinomas, respectively. The loss at 1q21.1 is associated with congenital heart disease [64] , while 12p13.33 deletion is related to lung cancer [65] . Through the above analysis, we found the three methods to be very effective; they detected many valuable CNVs, which can provide highly valuable information to aid clinical treatment.
IV. DISCUSSION AND CONCLUSION
In this article, we present CRSCNV, a simple and effective cross-model-based method for CNV detection in NGS data. CRSCNV has some new features that are absent in already published methods. Generally, the method uses circular binary segmentation [66] . Here, the division is executed in two steps. In the first step, the read depth sequence is divided into N -folds (segments), which are contiguous and mutually exclusive. Based on the above division, the N segments are randomly divided into 1-fold and (N − 1)-folds, which are also mutually exclusive, and have N ways of dividing. The division generates N 1-folds (test sets) and N (N − 1)-folds (training sets), both of which correspond in each division. We use N (N − 1)-folds data to fit N Gaussian models, by which the significance level of the N test sets data is evaluated, and hypothesis testing is performed to predict candidate CNVs. The general method for modeling data, that contains the detected data, is fixed in the experiment. In this case, some insignificant variations are difficult to be spotted in the detected data. This can easily cause over-fitting of the data and improves the conservation of test results. In our method, part of the data is used as the detected data. The other part of the data is used to build the model. In each test, the detected and modeled data change in a mutually exclusive fashion. This detection process reduces the conservativeness of the test results. Some meagre CNV regions are easily detected, and are validated in simulation experiments. For example, CRSCNV detects more heterozygote deletion regions than other methods. In particular, it performs well in detecting tumor samples with low purity. In order to verify the validity of CRSCNV, we applied it to detect CNVs in simulation and real data sets. In the simulation experiment, our method achieved the best F1-scores when compared to the other methods. In the real data experiments, CRSCNV detected a large number of CNVs, some of which are associated with breast cancer and other complex diseases. These detection results of CRSCNV clearly demonstrate its superiority over the other methods.
Based on the above reported experiments, there are some shortcomings in the CRSCNV method. For example, the run time of the method depends largely on the value of N . If the value of N is large, it will result in a high run time. Also, the size of bin cannot be acquired automatically by this method. The range of bins can satisfy most of the resolution requirements, but it cannot satisfy some extreme CNVs detection. TV is a common noise reduction algorithm in CNV detection [46] , but it influences the final performance. In the simulation experiment, we found that it can erroneously denoise some signals. In particular, the signals in the loss and normal areas appear rather similar. Furthermore, copy numbers in adjacent positions are usually correlated, making it necessary to smooth the genome. In general, using TV to reduce noise is more beneficial than the disadvantage it introduces to CNV detection. In future work, we will further improve the performance of CRSCNV by combining it with other detection methods [67] . According to the characteristics of the detected data, we will enable the method to automatically select and optimize parameters. We will also expand the functionality of the method, adding capacities such as calculating the absolute copy number, defining the boundaries of the CNV regions, and assessing tumor purity. These tasks are very important for us to accurately define the baseline. CNVs detection is a very challenging undertaking due to various deviations in the NGS data. Through the above improvements, CRSCNV could be applied to more scenarios and accurately and effectively predict CNVs. 
